| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0075 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |